| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF729 ZNF823 ZNF355P ZNF490 ZNF778 ZNF799 ZNF80 ZNF229 ZNF493 FEZF1 ZNF43 ZNF268 ZNF726 ZNF728 ZNF77 | 6.06e-07 | 1412 | 48 | 15 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF729 ZNF823 ZNF355P ZNF490 ZNF778 ZNF799 ZNF80 ZNF229 ZNF493 FEZF1 ZNF43 ZNF268 ZNF726 ZNF728 ZNF77 | 9.18e-07 | 1459 | 48 | 15 | GO:0000977 |
| GeneOntologyMolecularFunction | cytokine binding | 2.01e-06 | 157 | 48 | 6 | GO:0019955 | |
| GeneOntologyMolecularFunction | insulin receptor activity | 1.69e-05 | 3 | 48 | 2 | GO:0005009 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.79e-05 | 65 | 48 | 4 | GO:0004714 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 5.16e-05 | 85 | 48 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | C-X3-C chemokine binding | 5.63e-05 | 5 | 48 | 2 | GO:0019960 | |
| GeneOntologyMolecularFunction | integrin binding | 6.16e-05 | 175 | 48 | 5 | GO:0005178 | |
| GeneOntologyMolecularFunction | tumor necrosis factor binding | 1.18e-04 | 7 | 48 | 2 | GO:0043120 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF729 ZNF355P ZNF490 ZNF778 ZNF229 ZNF493 FEZF1 ZNF43 ZNF268 ZNF726 ZNF728 | 1.40e-04 | 1244 | 48 | 11 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF729 ZNF355P ZNF490 ZNF778 ZNF229 ZNF493 FEZF1 ZNF43 ZNF268 ZNF726 ZNF728 | 1.69e-04 | 1271 | 48 | 11 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 3.57e-04 | 560 | 48 | 7 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 3.80e-04 | 566 | 48 | 7 | GO:0001216 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 4.05e-04 | 145 | 48 | 4 | GO:0004713 | |
| GeneOntologyMolecularFunction | insulin-like growth factor I binding | 4.34e-04 | 13 | 48 | 2 | GO:0031994 | |
| GeneOntologyMolecularFunction | growth factor binding | 5.34e-04 | 156 | 48 | 4 | GO:0019838 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 5.34e-04 | 599 | 48 | 7 | GO:0050839 | |
| GeneOntologyMolecularFunction | insulin receptor substrate binding | 5.82e-04 | 15 | 48 | 2 | GO:0043560 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 9.43e-04 | 19 | 48 | 2 | GO:0005520 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 9.97e-04 | 320 | 48 | 5 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.08e-03 | 326 | 48 | 5 | GO:0001217 | |
| GeneOntologyMolecularFunction | virus receptor activity | 1.12e-03 | 85 | 48 | 3 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 1.16e-03 | 86 | 48 | 3 | GO:0140272 | |
| GeneOntologyMolecularFunction | protein-hormone receptor activity | 1.27e-03 | 22 | 48 | 2 | GO:0016500 | |
| GeneOntologyMolecularFunction | chemokine binding | 2.85e-03 | 33 | 48 | 2 | GO:0019956 | |
| GeneOntologyMolecularFunction | sphingolipid binding | 3.02e-03 | 34 | 48 | 2 | GO:0046625 | |
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme binding | 3.38e-03 | 36 | 48 | 2 | GO:0031624 | |
| GeneOntologyMolecularFunction | protein kinase regulator activity | 3.44e-03 | 259 | 48 | 4 | GO:0019887 | |
| GeneOntologyMolecularFunction | fibronectin binding | 3.76e-03 | 38 | 48 | 2 | GO:0001968 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein conjugating enzyme binding | 4.58e-03 | 42 | 48 | 2 | GO:0044390 | |
| GeneOntologyMolecularFunction | protein kinase binding | 4.59e-03 | 873 | 48 | 7 | GO:0019901 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 4.80e-03 | 43 | 48 | 2 | GO:0043548 | |
| GeneOntologyMolecularFunction | protein kinase activator activity | 5.51e-03 | 149 | 48 | 3 | GO:0030295 | |
| GeneOntologyMolecularFunction | kinase regulator activity | 6.12e-03 | 305 | 48 | 4 | GO:0019207 | |
| GeneOntologyMolecularFunction | kinase activator activity | 6.59e-03 | 159 | 48 | 3 | GO:0019209 | |
| GeneOntologyMolecularFunction | kinase binding | 8.02e-03 | 969 | 48 | 7 | GO:0019900 | |
| GeneOntologyMolecularFunction | cadherin binding | 8.83e-03 | 339 | 48 | 4 | GO:0045296 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 1.10e-02 | 66 | 48 | 2 | GO:0005080 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 2.43e-08 | 412 | 47 | 10 | GO:0090287 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | VWC2L SPRY2 ADAM17 LTBP3 IGF1R MT3 BMPER CHRDL2 EGFR FST ITGB1 ITGB3 SPRY4 EPHA4 INSRR | 2.99e-08 | 1186 | 47 | 15 | GO:0007167 |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | VWC2L SPRY2 ADAM17 LTBP3 IGF1R MT3 BMPER CHRDL2 EGFR FST ITGB1 ITGB3 SPRY4 | 3.46e-08 | 850 | 47 | 13 | GO:0071363 |
| GeneOntologyBiologicalProcess | response to growth factor | VWC2L SPRY2 ADAM17 LTBP3 IGF1R MT3 BMPER CHRDL2 EGFR FST ITGB1 ITGB3 SPRY4 | 5.41e-08 | 883 | 47 | 13 | GO:0070848 |
| GeneOntologyBiologicalProcess | regulation of kinase activity | 2.64e-06 | 686 | 47 | 10 | GO:0043549 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 3.32e-06 | 405 | 47 | 8 | GO:0033674 | |
| GeneOntologyBiologicalProcess | transposable element silencing | 3.60e-06 | 46 | 47 | 4 | GO:0010526 | |
| GeneOntologyBiologicalProcess | retrotransposition | 4.28e-06 | 48 | 47 | 4 | GO:0032197 | |
| GeneOntologyBiologicalProcess | positive regulation of MAPK cascade | 4.78e-06 | 571 | 47 | 9 | GO:0043410 | |
| GeneOntologyBiologicalProcess | transposition | 5.05e-06 | 50 | 47 | 4 | GO:0032196 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | 5.62e-06 | 747 | 47 | 10 | GO:0007169 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 6.63e-06 | 445 | 47 | 8 | GO:0141091 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | 8.21e-06 | 780 | 47 | 10 | GO:0042327 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 9.16e-06 | 619 | 47 | 9 | GO:0002009 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 9.73e-06 | 218 | 47 | 6 | GO:0090101 | |
| GeneOntologyBiologicalProcess | regulation of transferase activity | 1.14e-05 | 810 | 47 | 10 | GO:0051338 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.18e-05 | 482 | 47 | 8 | GO:0007178 | |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | 1.20e-05 | 815 | 47 | 10 | GO:0043408 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | 1.33e-05 | 490 | 47 | 8 | GO:0051347 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic neurotransmitter receptor diffusion trapping | 1.52e-05 | 3 | 47 | 2 | GO:0150054 | |
| GeneOntologyBiologicalProcess | positive regulation of ERK1 and ERK2 cascade | 1.68e-05 | 240 | 47 | 6 | GO:0070374 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular response to growth factor stimulus | 2.28e-05 | 150 | 47 | 5 | GO:0090288 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | 2.31e-05 | 879 | 47 | 10 | GO:0045937 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | 2.31e-05 | 879 | 47 | 10 | GO:0010562 | |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | 2.47e-05 | 385 | 47 | 7 | GO:0070372 | |
| GeneOntologyBiologicalProcess | positive regulation of bone resorption | 3.49e-05 | 28 | 47 | 3 | GO:0045780 | |
| GeneOntologyBiologicalProcess | MAPK cascade | 3.74e-05 | 930 | 47 | 10 | GO:0000165 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | VWC2L CCN6 NELL1 LAMC1 LTBP3 EGFR FEZF1 ITGB1 ITGB3 ZNF268 EPHA4 | 3.91e-05 | 1141 | 47 | 11 | GO:0045597 |
| GeneOntologyBiologicalProcess | ERK1 and ERK2 cascade | 4.17e-05 | 418 | 47 | 7 | GO:0070371 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 4.17e-05 | 750 | 47 | 9 | GO:0048729 | |
| GeneOntologyBiologicalProcess | sex determination | 4.77e-05 | 31 | 47 | 3 | GO:0007530 | |
| GeneOntologyBiologicalProcess | regulation of osteoblast proliferation | 6.31e-05 | 34 | 47 | 3 | GO:0033688 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase activity | 6.42e-05 | 611 | 47 | 8 | GO:0045859 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | SPRY2 TRAF2 ADAM17 IGF1R MT3 EGFR ITGB1 ITGB3 SPRY4 EPHA4 INSRR | 7.50e-05 | 1226 | 47 | 11 | GO:0042325 |
| GeneOntologyBiologicalProcess | regulation of MAP kinase activity | 7.78e-05 | 194 | 47 | 5 | GO:0043405 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 8.79e-05 | 826 | 47 | 9 | GO:0048858 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine phosphorylation | 9.42e-05 | 327 | 47 | 6 | GO:0018108 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine modification | 9.74e-05 | 329 | 47 | 6 | GO:0018212 | |
| GeneOntologyBiologicalProcess | regulation of axon regeneration | 1.03e-04 | 40 | 47 | 3 | GO:0048679 | |
| GeneOntologyBiologicalProcess | osteoblast proliferation | 1.11e-04 | 41 | 47 | 3 | GO:0033687 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular signal transduction | TSPAN6 SPRY2 TRAF2 ADAM17 IGF1R MT3 BMPER EGFR ITGB1 ITGB3 EPHA4 | 1.26e-04 | 1299 | 47 | 11 | GO:1902533 |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.30e-04 | 347 | 47 | 6 | GO:0090092 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | 1.37e-04 | 350 | 47 | 6 | GO:0045860 | |
| GeneOntologyBiologicalProcess | regulation of fibroblast growth factor receptor signaling pathway | 1.38e-04 | 44 | 47 | 3 | GO:0040036 | |
| GeneOntologyBiologicalProcess | positive regulation of cell migration | 1.51e-04 | 691 | 47 | 8 | GO:0030335 | |
| GeneOntologyBiologicalProcess | regulation of protein serine/threonine kinase activity | 1.54e-04 | 358 | 47 | 6 | GO:0071900 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection regeneration | 1.68e-04 | 47 | 47 | 3 | GO:0070570 | |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 1.84e-04 | 233 | 47 | 5 | GO:0031345 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | 1.93e-04 | 1133 | 47 | 10 | GO:0043066 | |
| GeneOntologyBiologicalProcess | positive regulation of protein phosphorylation | 2.07e-04 | 724 | 47 | 8 | GO:0001934 | |
| GeneOntologyBiologicalProcess | positive regulation of cell motility | 2.09e-04 | 725 | 47 | 8 | GO:2000147 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 2.24e-04 | 131 | 47 | 4 | GO:0030510 | |
| GeneOntologyBiologicalProcess | positive regulation of locomotion | 2.45e-04 | 742 | 47 | 8 | GO:0040017 | |
| GeneOntologyBiologicalProcess | negative regulation of programmed cell death | 2.53e-04 | 1171 | 47 | 10 | GO:0043069 | |
| GeneOntologyBiologicalProcess | axonogenesis | 2.74e-04 | 566 | 47 | 7 | GO:0007409 | |
| GeneOntologyBiologicalProcess | regulation of synapse pruning | 2.76e-04 | 11 | 47 | 2 | GO:1905806 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | SPRY2 TRAF2 ADAM17 IGF1R MT3 EGFR ITGB1 ITGB3 SPRY4 EPHA4 INSRR | 2.76e-04 | 1421 | 47 | 11 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | SPRY2 TRAF2 ADAM17 IGF1R MT3 EGFR ITGB1 ITGB3 SPRY4 EPHA4 INSRR | 2.80e-04 | 1423 | 47 | 11 | GO:0051174 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | 3.08e-04 | 976 | 47 | 9 | GO:0018193 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-tyrosine phosphorylation | 3.75e-04 | 272 | 47 | 5 | GO:0050730 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor diffusion trapping | 3.90e-04 | 13 | 47 | 2 | GO:0099628 | |
| GeneOntologyBiologicalProcess | postsynaptic neurotransmitter receptor diffusion trapping | 3.90e-04 | 13 | 47 | 2 | GO:0098970 | |
| GeneOntologyBiologicalProcess | cellular response to insulin-like growth factor stimulus | 3.90e-04 | 13 | 47 | 2 | GO:1990314 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 4.13e-04 | 802 | 47 | 8 | GO:0048812 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | 4.51e-04 | 1028 | 47 | 9 | GO:0043085 | |
| GeneOntologyBiologicalProcess | receptor diffusion trapping | 4.54e-04 | 14 | 47 | 2 | GO:0098953 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor-mediated signaling pathway | 4.54e-04 | 14 | 47 | 2 | GO:1903265 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 4.75e-04 | 819 | 47 | 8 | GO:0120039 | |
| GeneOntologyBiologicalProcess | negative regulation of small GTPase mediated signal transduction | 4.80e-04 | 67 | 47 | 3 | GO:0051058 | |
| GeneOntologyBiologicalProcess | axon regeneration | 5.23e-04 | 69 | 47 | 3 | GO:0031103 | |
| GeneOntologyBiologicalProcess | regulation of protein tyrosine kinase activity | 5.23e-04 | 69 | 47 | 3 | GO:0061097 | |
| GeneOntologyBiologicalProcess | positive regulation of osteoblast proliferation | 5.24e-04 | 15 | 47 | 2 | GO:0033690 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 5.45e-04 | 70 | 47 | 3 | GO:0045124 | |
| GeneOntologyBiologicalProcess | axon development | 5.84e-04 | 642 | 47 | 7 | GO:0061564 | |
| GeneOntologyBiologicalProcess | male sex determination | 5.98e-04 | 16 | 47 | 2 | GO:0030238 | |
| GeneOntologyBiologicalProcess | cellular response to mechanical stimulus | 6.17e-04 | 73 | 47 | 3 | GO:0071260 | |
| GeneOntologyBiologicalProcess | cellular response to external stimulus | 6.42e-04 | 74 | 47 | 3 | GO:0071496 | |
| GeneOntologyBiologicalProcess | maintenance of postsynaptic specialization structure | 6.76e-04 | 17 | 47 | 2 | GO:0098880 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | 7.34e-04 | 875 | 47 | 8 | GO:0045596 | |
| GeneOntologyBiologicalProcess | negative regulation of BMP signaling pathway | 8.06e-04 | 80 | 47 | 3 | GO:0030514 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 8.06e-04 | 80 | 47 | 3 | GO:0046850 | |
| GeneOntologyBiologicalProcess | neuron projection regeneration | 8.35e-04 | 81 | 47 | 3 | GO:0031102 | |
| GeneOntologyBiologicalProcess | synapse pruning | 8.48e-04 | 19 | 47 | 2 | GO:0098883 | |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | 9.07e-04 | 1133 | 47 | 9 | GO:0001932 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 9.49e-04 | 334 | 47 | 5 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 9.49e-04 | 334 | 47 | 5 | GO:0001894 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-tyrosine phosphorylation | 9.68e-04 | 193 | 47 | 4 | GO:0050731 | |
| GeneOntologyBiologicalProcess | positive regulation of protein serine/threonine kinase activity | 9.68e-04 | 193 | 47 | 4 | GO:0071902 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 9.75e-04 | 336 | 47 | 5 | GO:0071560 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 9.94e-04 | 86 | 47 | 3 | GO:0042058 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 1.04e-03 | 197 | 47 | 4 | GO:0030509 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 1.07e-03 | 343 | 47 | 5 | GO:0071559 | |
| GeneOntologyBiologicalProcess | negative regulation of MAPK cascade | 1.12e-03 | 201 | 47 | 4 | GO:0043409 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine autophosphorylation | 1.14e-03 | 22 | 47 | 2 | GO:0038083 | |
| GeneOntologyBiologicalProcess | positive regulation of protein modification process | 1.14e-03 | 937 | 47 | 8 | GO:0031401 | |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 1.17e-03 | 91 | 47 | 3 | GO:0033627 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 1.25e-03 | 93 | 47 | 3 | GO:1901184 | |
| GeneOntologyBiologicalProcess | negative regulation of gene expression via chromosomal CpG island methylation | 1.25e-03 | 23 | 47 | 2 | GO:0044027 | |
| GeneOntologyBiologicalProcess | positive regulation of vascular endothelial growth factor receptor signaling pathway | 1.25e-03 | 23 | 47 | 2 | GO:0030949 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | 1.28e-03 | 1190 | 47 | 9 | GO:0008284 | |
| GeneOntologyCellularComponent | ruffle membrane | 1.49e-07 | 108 | 47 | 6 | GO:0032587 | |
| GeneOntologyCellularComponent | ruffle | 6.53e-06 | 206 | 47 | 6 | GO:0001726 | |
| GeneOntologyCellularComponent | leading edge membrane | 7.29e-06 | 210 | 47 | 6 | GO:0031256 | |
| GeneOntologyCellularComponent | integrin alpha9-beta1 complex | 1.48e-05 | 3 | 47 | 2 | GO:0034679 | |
| GeneOntologyCellularComponent | alphav-beta3 integrin-IGF-1-IGF1R complex | 2.96e-05 | 4 | 47 | 2 | GO:0035867 | |
| GeneOntologyCellularComponent | insulin receptor complex | 2.96e-05 | 4 | 47 | 2 | GO:0005899 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 1.27e-04 | 350 | 47 | 6 | GO:0098802 | |
| GeneOntologyCellularComponent | receptor complex | 2.96e-04 | 581 | 47 | 7 | GO:0043235 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 3.17e-04 | 59 | 47 | 3 | GO:0098636 | |
| GeneOntologyCellularComponent | cell projection membrane | 3.90e-04 | 431 | 47 | 6 | GO:0031253 | |
| GeneOntologyCellularComponent | focal adhesion | 3.90e-04 | 431 | 47 | 6 | GO:0005925 | |
| GeneOntologyCellularComponent | cell-substrate junction | 4.51e-04 | 443 | 47 | 6 | GO:0030055 | |
| GeneOntologyCellularComponent | cell leading edge | 8.49e-04 | 500 | 47 | 6 | GO:0031252 | |
| GeneOntologyCellularComponent | glycinergic synapse | 9.16e-04 | 20 | 47 | 2 | GO:0098690 | |
| GeneOntologyCellularComponent | membrane raft | 1.28e-03 | 362 | 47 | 5 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 1.31e-03 | 364 | 47 | 5 | GO:0098857 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 1.74e-03 | 785 | 47 | 7 | GO:0098797 | |
| GeneOntologyCellularComponent | neuromuscular junction | 2.05e-03 | 112 | 47 | 3 | GO:0031594 | |
| GeneOntologyCellularComponent | integrin complex | 2.35e-03 | 32 | 47 | 2 | GO:0008305 | |
| GeneOntologyCellularComponent | filopodium | 2.67e-03 | 123 | 47 | 3 | GO:0030175 | |
| GeneOntologyCellularComponent | extracellular matrix | 3.36e-03 | 656 | 47 | 6 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 3.41e-03 | 658 | 47 | 6 | GO:0030312 | |
| GeneOntologyCellularComponent | glial cell projection | 5.01e-03 | 47 | 47 | 2 | GO:0097386 | |
| GeneOntologyCellularComponent | anchoring junction | 5.82e-03 | 976 | 47 | 7 | GO:0070161 | |
| HumanPheno | Otitis externa | 1.27e-05 | 3 | 11 | 2 | HP:0410017 | |
| HumanPheno | Perianal dermatitis | 1.27e-05 | 3 | 11 | 2 | HP:0011131 | |
| HumanPheno | Chronic monilial nail infection | 1.27e-05 | 3 | 11 | 2 | HP:0008396 | |
| HumanPheno | Slow-growing scalp hair | 2.54e-05 | 4 | 11 | 2 | HP:0100038 | |
| HumanPheno | Chapped lip | 2.54e-05 | 4 | 11 | 2 | HP:0040181 | |
| HumanPheno | Anal fissure | 4.22e-05 | 5 | 11 | 2 | HP:0012390 | |
| HumanPheno | Bloody diarrhea | 1.39e-04 | 50 | 11 | 3 | HP:0025085 | |
| HumanPheno | Recurrent gastroenteritis | 3.80e-04 | 14 | 11 | 2 | HP:0031123 | |
| HumanPheno | Skeletal dysplasia | 4.64e-04 | 186 | 11 | 4 | HP:0002652 | |
| MousePheno | respiratory failure | 3.59e-06 | 165 | 36 | 6 | MP:0001953 | |
| MousePheno | decreased respiration | 4.26e-06 | 170 | 36 | 6 | MP:0014274 | |
| MousePheno | thick lung-associated mesenchyme | 1.74e-05 | 20 | 36 | 3 | MP:0011143 | |
| MousePheno | decreased fetal size | 2.34e-05 | 229 | 36 | 6 | MP:0004200 | |
| MousePheno | abnormal fetal size | 2.84e-05 | 237 | 36 | 6 | MP:0004198 | |
| MousePheno | abnormal lung saccule morphology | 5.47e-05 | 29 | 36 | 3 | MP:0010825 | |
| MousePheno | perinatal lethality | NELL1 LAMC1 TRAF2 ADAM17 IGF1R BMPER EGFR FST FEZF1 ITGB1 ITGB3 | 8.32e-05 | 1130 | 36 | 11 | MP:0002081 |
| MousePheno | abnormal branching involved in lung morphogenesis | 8.89e-05 | 34 | 36 | 3 | MP:0011024 | |
| MousePheno | cornea scarring | 9.61e-05 | 6 | 36 | 2 | MP:0001316 | |
| MousePheno | abnormal skeleton development | 1.22e-04 | 447 | 36 | 7 | MP:0002113 | |
| MousePheno | abnormal fetal growth/weight/body size | 1.30e-04 | 312 | 36 | 6 | MP:0004197 | |
| MousePheno | enlarged frontal bone | 1.34e-04 | 7 | 36 | 2 | MP:0004375 | |
| MousePheno | enlarged interparietal bone | 1.34e-04 | 7 | 36 | 2 | MP:0004386 | |
| MousePheno | abnormal nose morphology | 1.53e-04 | 201 | 36 | 5 | MP:0002233 | |
| MousePheno | abnormal cranium morphology | 1.65e-04 | 813 | 36 | 9 | MP:0000438 | |
| MousePheno | enlarged aortic valve | 1.79e-04 | 8 | 36 | 2 | MP:0010591 | |
| MousePheno | abnormal craniofacial bone morphology | 1.88e-04 | 827 | 36 | 9 | MP:0002116 | |
| MousePheno | abnormal respiratory system morphology | 1.91e-04 | 1027 | 36 | 10 | MP:0002132 | |
| MousePheno | abnormal cartilage morphology | 1.95e-04 | 336 | 36 | 6 | MP:0000163 | |
| MousePheno | small supraoccipital bone | 2.30e-04 | 9 | 36 | 2 | MP:0004444 | |
| MousePheno | distorted hair follicle pattern | 2.30e-04 | 9 | 36 | 2 | MP:0000384 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | NELL1 LAMC1 TRAF2 ADAM17 IGF1R BMPER EGFR FST FEZF1 ITGB1 ARIH2 | 2.35e-04 | 1269 | 36 | 11 | MP:0011111 |
| MousePheno | malocclusion | 2.35e-04 | 47 | 36 | 3 | MP:0000120 | |
| MousePheno | abnormal interparietal bone morphology | 2.51e-04 | 48 | 36 | 3 | MP:0000077 | |
| MousePheno | cyanosis | 2.65e-04 | 226 | 36 | 5 | MP:0001575 | |
| MousePheno | abnormal respiratory epithelium morphology | 3.17e-04 | 235 | 36 | 5 | MP:0010942 | |
| MousePheno | misaligned teeth | 3.18e-04 | 52 | 36 | 3 | MP:0030540 | |
| MousePheno | decreased skeletal muscle mass | 3.44e-04 | 131 | 36 | 4 | MP:0004819 | |
| MousePheno | petechiae | 3.50e-04 | 11 | 36 | 2 | MP:0008816 | |
| MousePheno | enlarged semilunar valve | 3.50e-04 | 11 | 36 | 2 | MP:0031580 | |
| MousePheno | perinatal lethality, complete penetrance | 3.70e-04 | 712 | 36 | 8 | MP:0011089 | |
| MousePheno | abnormal facial morphology | 3.84e-04 | 910 | 36 | 9 | MP:0003743 | |
| MousePheno | abnormal tooth number | 3.96e-04 | 56 | 36 | 3 | MP:0030611 | |
| MousePheno | craniofacial phenotype | NELL1 SPRY2 LTBP3 IGF1R BMPER EGFR FST FEZF1 ITGB1 NSD3 SPRY4 | 4.64e-04 | 1372 | 36 | 11 | MP:0005382 |
| MousePheno | abnormal craniofacial morphology | NELL1 SPRY2 LTBP3 IGF1R BMPER EGFR FST FEZF1 ITGB1 NSD3 SPRY4 | 4.64e-04 | 1372 | 36 | 11 | MP:0000428 |
| MousePheno | abnormal lung development | 4.67e-04 | 142 | 36 | 4 | MP:0001176 | |
| MousePheno | abnormal oxygen level | 4.69e-04 | 256 | 36 | 5 | MP:0001574 | |
| MousePheno | supernumerary teeth | 4.94e-04 | 13 | 36 | 2 | MP:0004033 | |
| MousePheno | abnormal skeletal muscle mass | 5.60e-04 | 149 | 36 | 4 | MP:0004817 | |
| MousePheno | osteosclerosis | 5.75e-04 | 14 | 36 | 2 | MP:0005422 | |
| MousePheno | abnormal neurocranium morphology | 5.88e-04 | 269 | 36 | 5 | MP:0000074 | |
| MousePheno | abnormal temporal bone morphology | 6.42e-04 | 66 | 36 | 3 | MP:0005272 | |
| MousePheno | abnormal esophagus morphology | 6.42e-04 | 66 | 36 | 3 | MP:0000467 | |
| MousePheno | abnormal transforming growth factor beta level | 6.63e-04 | 15 | 36 | 2 | MP:0008836 | |
| MousePheno | abnormal viscerocranium morphology | 6.81e-04 | 593 | 36 | 7 | MP:0005274 | |
| MousePheno | abnormal craniofacial development | 6.85e-04 | 425 | 36 | 6 | MP:0003935 | |
| MousePheno | abnormal gas homeostasis | 7.30e-04 | 600 | 36 | 7 | MP:0003948 | |
| MousePheno | dermatitis | 7.31e-04 | 69 | 36 | 3 | MP:0001194 | |
| MousePheno | abnormal respiratory system development | 7.32e-04 | 160 | 36 | 4 | MP:0003115 | |
| MousePheno | dilated respiratory conducting tube | 8.56e-04 | 17 | 36 | 2 | MP:0010856 | |
| MousePheno | abnormal cartilage development | 9.59e-04 | 172 | 36 | 4 | MP:0000164 | |
| MousePheno | abnormal frontal bone morphology | 1.01e-03 | 77 | 36 | 3 | MP:0000107 | |
| MousePheno | abnormal mandible morphology | 1.04e-03 | 176 | 36 | 4 | MP:0000458 | |
| MousePheno | small vertebral body | 1.07e-03 | 19 | 36 | 2 | MP:0004670 | |
| MousePheno | abnormal hair follicle orientation | 1.07e-03 | 19 | 36 | 2 | MP:0000383 | |
| MousePheno | abnormal respiratory conducting tube morphology | 1.08e-03 | 79 | 36 | 3 | MP:0004391 | |
| MousePheno | decreased spongiotrophoblast size | 1.19e-03 | 20 | 36 | 2 | MP:0012099 | |
| MousePheno | short vibrissae | 1.19e-03 | 20 | 36 | 2 | MP:0001282 | |
| MousePheno | abnormal bronchiole epithelium morphology | 1.19e-03 | 20 | 36 | 2 | MP:0010897 | |
| MousePheno | failure of eyelid fusion | 1.19e-03 | 20 | 36 | 2 | MP:0009264 | |
| MousePheno | decreased eosinophil cell number | 1.30e-03 | 84 | 36 | 3 | MP:0005012 | |
| MousePheno | decreased cornea thickness | 1.31e-03 | 21 | 36 | 2 | MP:0005543 | |
| MousePheno | small interparietal bone | 1.31e-03 | 21 | 36 | 2 | MP:0004384 | |
| MousePheno | abnormal induced retina neovascularization | 1.31e-03 | 21 | 36 | 2 | MP:0009660 | |
| MousePheno | waved hair | 1.31e-03 | 21 | 36 | 2 | MP:0000410 | |
| MousePheno | abnormal cartilaginous joint morphology | 1.34e-03 | 85 | 36 | 3 | MP:0030875 | |
| MousePheno | postnatal lethality, incomplete penetrance | 1.38e-03 | 669 | 36 | 7 | MP:0011086 | |
| MousePheno | abnormal placenta labyrinth morphology | 1.50e-03 | 194 | 36 | 4 | MP:0001716 | |
| MousePheno | perinatal lethality, incomplete penetrance | 1.64e-03 | 503 | 36 | 6 | MP:0011090 | |
| MousePheno | abnormal head morphology | 1.71e-03 | 1120 | 36 | 9 | MP:0000432 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | 1.75e-03 | 1124 | 36 | 9 | MP:0011112 | |
| MousePheno | abnormal occipital bone morphology | 1.85e-03 | 95 | 36 | 3 | MP:0005269 | |
| MousePheno | abnormal olfactory sensory neuron morphology | 1.86e-03 | 25 | 36 | 2 | MP:0006092 | |
| MousePheno | abnormal quadriceps morphology | 1.86e-03 | 25 | 36 | 2 | MP:0010225 | |
| MousePheno | curly vibrissae | 2.02e-03 | 26 | 36 | 2 | MP:0001274 | |
| MousePheno | abnormal trophoblast layer morphology | 2.04e-03 | 211 | 36 | 4 | MP:0005031 | |
| MousePheno | abnormal jaw morphology | 2.13e-03 | 530 | 36 | 6 | MP:0000454 | |
| MousePheno | thick aortic valve | 2.17e-03 | 27 | 36 | 2 | MP:0010594 | |
| MousePheno | maternal imprinting | 2.34e-03 | 28 | 36 | 2 | MP:0003122 | |
| MousePheno | abnormal spongiotrophoblast size | 2.34e-03 | 28 | 36 | 2 | MP:0012097 | |
| MousePheno | short facial bone | 2.39e-03 | 104 | 36 | 3 | MP:0030384 | |
| MousePheno | skin inflammation | 2.46e-03 | 105 | 36 | 3 | MP:0004947 | |
| MousePheno | abnormal supraoccipital bone morphology | 2.51e-03 | 29 | 36 | 2 | MP:0000078 | |
| MousePheno | enhanced wound healing | 2.51e-03 | 29 | 36 | 2 | MP:0002724 | |
| MousePheno | abnormal eyelid fusion | 2.51e-03 | 29 | 36 | 2 | MP:0009263 | |
| MousePheno | abnormal presacral vertebrae morphology | 2.57e-03 | 225 | 36 | 4 | MP:0000459 | |
| MousePheno | abnormal tooth development | 2.66e-03 | 108 | 36 | 3 | MP:0000116 | |
| MousePheno | pathological neovascularization | 2.66e-03 | 108 | 36 | 3 | MP:0003711 | |
| MousePheno | abnormal chemoreceptor morphology | 2.68e-03 | 30 | 36 | 2 | MP:0001001 | |
| Domain | zf-C2H2_6 | ZNF729 ZNF823 ZNF490 ZNF778 ZNF799 ZNF80 ZNF229 ZNF493 FEZF1 ZNF43 ZNF726 ZNF728 ZNF77 | 5.64e-13 | 314 | 47 | 13 | PF13912 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF729 ZNF823 ZNF490 ZNF778 ZNF799 ZNF80 ZNF229 ZNF493 ZC3H7B FEZF1 ZNF43 ZNF268 ZNF726 ZNF728 ZNF77 | 3.54e-10 | 775 | 47 | 15 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF729 ZNF823 ZNF490 ZNF778 ZNF799 ZNF80 ZNF229 ZNF493 ZC3H7B FEZF1 ZNF43 ZNF268 ZNF726 ZNF728 ZNF77 | 3.67e-10 | 777 | 47 | 15 | PS00028 |
| Domain | Znf_C2H2-like | ZNF729 ZNF823 ZNF490 ZNF778 ZNF799 ZNF80 ZNF229 ZNF493 ZC3H7B FEZF1 ZNF43 ZNF268 ZNF726 ZNF728 ZNF77 | 5.12e-10 | 796 | 47 | 15 | IPR015880 |
| Domain | Znf_C2H2 | ZNF729 ZNF823 ZNF490 ZNF778 ZNF799 ZNF80 ZNF229 ZNF493 ZC3H7B FEZF1 ZNF43 ZNF268 ZNF726 ZNF728 ZNF77 | 5.98e-10 | 805 | 47 | 15 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF729 ZNF823 ZNF490 ZNF778 ZNF799 ZNF80 ZNF229 ZNF493 ZC3H7B FEZF1 ZNF43 ZNF268 ZNF726 ZNF728 ZNF77 | 6.30e-10 | 808 | 47 | 15 | SM00355 |
| Domain | - | ZNF729 ZNF823 ZNF490 ZNF778 ZNF799 ZNF80 ZNF229 ZNF493 FEZF1 ZNF43 ZNF268 ZNF726 ZNF728 ZNF77 | 6.94e-10 | 679 | 47 | 14 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF729 ZNF823 ZNF490 ZNF778 ZNF799 ZNF80 ZNF229 ZNF493 FEZF1 ZNF43 ZNF268 ZNF726 ZNF728 ZNF77 | 9.04e-10 | 693 | 47 | 14 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF729 ZNF823 ZNF490 ZNF778 ZNF799 ZNF80 ZNF229 ZNF493 FEZF1 ZNF43 ZNF268 ZNF726 ZNF728 ZNF77 | 9.21e-10 | 694 | 47 | 14 | IPR013087 |
| Domain | KRAB | ZNF729 ZNF823 ZNF490 ZNF778 ZNF799 ZNF229 ZNF43 ZNF268 ZNF726 ZNF728 ZNF77 | 1.03e-09 | 358 | 47 | 11 | PS50805 |
| Domain | KRAB | ZNF729 ZNF823 ZNF490 ZNF778 ZNF799 ZNF229 ZNF43 ZNF268 ZNF726 ZNF728 ZNF77 | 1.03e-09 | 358 | 47 | 11 | PF01352 |
| Domain | KRAB | ZNF729 ZNF823 ZNF490 ZNF778 ZNF799 ZNF229 ZNF43 ZNF268 ZNF726 ZNF728 ZNF77 | 1.42e-09 | 369 | 47 | 11 | SM00349 |
| Domain | KRAB | ZNF729 ZNF823 ZNF490 ZNF778 ZNF799 ZNF229 ZNF43 ZNF268 ZNF726 ZNF728 ZNF77 | 1.46e-09 | 370 | 47 | 11 | IPR001909 |
| Domain | Growth_fac_rcpt_ | 1.18e-07 | 156 | 47 | 7 | IPR009030 | |
| Domain | Furin-like | 5.19e-07 | 7 | 47 | 3 | PF00757 | |
| Domain | Rcpt_L-dom | 5.19e-07 | 7 | 47 | 3 | IPR000494 | |
| Domain | Furin-like_Cys-rich_dom | 5.19e-07 | 7 | 47 | 3 | IPR006211 | |
| Domain | Recep_L_domain | 5.19e-07 | 7 | 47 | 3 | PF01030 | |
| Domain | - | 5.19e-07 | 7 | 47 | 3 | 3.80.20.20 | |
| Domain | VWFC_1 | 1.95e-06 | 36 | 47 | 4 | PS01208 | |
| Domain | VWC | 2.44e-06 | 38 | 47 | 4 | SM00214 | |
| Domain | VWFC_2 | 2.44e-06 | 38 | 47 | 4 | PS50184 | |
| Domain | VWF_dom | 3.67e-06 | 42 | 47 | 4 | IPR001007 | |
| Domain | EGF-like_CS | 3.75e-06 | 261 | 47 | 7 | IPR013032 | |
| Domain | Furin_repeat | 1.19e-05 | 18 | 47 | 3 | IPR006212 | |
| Domain | FU | 1.19e-05 | 18 | 47 | 3 | SM00261 | |
| Domain | Tyr_kinase_insulin-like_rcpt | 1.86e-05 | 3 | 47 | 2 | IPR016246 | |
| Domain | WAP_dom | 2.22e-05 | 22 | 47 | 3 | IPR008197 | |
| Domain | - | 3.71e-05 | 4 | 47 | 2 | 1.20.5.630 | |
| Domain | EGF_1 | 4.10e-05 | 255 | 47 | 6 | PS00022 | |
| Domain | VWC | 4.68e-05 | 28 | 47 | 3 | PF00093 | |
| Domain | TyrKc | 7.03e-05 | 88 | 47 | 4 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 7.03e-05 | 88 | 47 | 4 | IPR020635 | |
| Domain | Integrin_bsu_cyt_dom | 9.24e-05 | 6 | 47 | 2 | IPR014836 | |
| Domain | Integrin_b_cyt | 9.24e-05 | 6 | 47 | 2 | SM01241 | |
| Domain | Integrin_b_cyt | 9.24e-05 | 6 | 47 | 2 | PF08725 | |
| Domain | PROTEIN_KINASE_TYR | 1.03e-04 | 97 | 47 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.03e-04 | 97 | 47 | 4 | IPR008266 | |
| Domain | SPR | 1.29e-04 | 7 | 47 | 2 | PS51227 | |
| Domain | Sprouty | 1.29e-04 | 7 | 47 | 2 | IPR007875 | |
| Domain | Integrin_bsu_tail | 1.29e-04 | 7 | 47 | 2 | IPR012896 | |
| Domain | Integrin_B_tail | 1.29e-04 | 7 | 47 | 2 | SM01242 | |
| Domain | Sprouty | 1.29e-04 | 7 | 47 | 2 | PF05210 | |
| Domain | Integrin_B_tail | 1.29e-04 | 7 | 47 | 2 | PF07965 | |
| Domain | INB | 1.72e-04 | 8 | 47 | 2 | SM00187 | |
| Domain | Integrin_beta | 1.72e-04 | 8 | 47 | 2 | PF00362 | |
| Domain | Integrin_bsu_VWA | 1.72e-04 | 8 | 47 | 2 | IPR002369 | |
| Domain | TB | 2.21e-04 | 9 | 47 | 2 | PS51364 | |
| Domain | Integrin_bsu | 2.21e-04 | 9 | 47 | 2 | IPR015812 | |
| Domain | TB_dom | 2.21e-04 | 9 | 47 | 2 | IPR017878 | |
| Domain | INTEGRIN_BETA | 2.21e-04 | 9 | 47 | 2 | PS00243 | |
| Domain | PSI_integrin | 2.21e-04 | 9 | 47 | 2 | PF17205 | |
| Domain | Integin_beta_N | 2.21e-04 | 9 | 47 | 2 | IPR033760 | |
| Domain | E3_UB_ligase_RBR | 2.75e-04 | 10 | 47 | 2 | IPR031127 | |
| Domain | Pkinase_Tyr | 3.08e-04 | 129 | 47 | 4 | PF07714 | |
| Domain | Tyr_kinase_rcpt_2_CS | 3.36e-04 | 11 | 47 | 2 | IPR002011 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 3.98e-04 | 138 | 47 | 4 | IPR001245 | |
| Domain | RECEPTOR_TYR_KIN_II | 4.03e-04 | 12 | 47 | 2 | PS00239 | |
| Domain | EGF_extracell | 4.62e-04 | 60 | 47 | 3 | IPR013111 | |
| Domain | EGF_2 | 4.62e-04 | 60 | 47 | 3 | PF07974 | |
| Domain | EGF_2 | 5.22e-04 | 265 | 47 | 5 | PS01186 | |
| Domain | IBR | 5.53e-04 | 14 | 47 | 2 | PF01485 | |
| Domain | IBR | 5.53e-04 | 14 | 47 | 2 | SM00647 | |
| Domain | IBR_dom | 6.37e-04 | 15 | 47 | 2 | IPR002867 | |
| Domain | WAP | 7.27e-04 | 16 | 47 | 2 | SM00217 | |
| Domain | WAP | 7.27e-04 | 16 | 47 | 2 | PF00095 | |
| Domain | Znf_RING_CS | 7.45e-04 | 163 | 47 | 4 | IPR017907 | |
| Domain | - | 8.23e-04 | 17 | 47 | 2 | 4.10.75.10 | |
| Domain | WAP | 8.23e-04 | 17 | 47 | 2 | PS51390 | |
| Domain | RING | 9.83e-04 | 305 | 47 | 5 | SM00184 | |
| Domain | - | 1.14e-03 | 20 | 47 | 2 | 4.10.70.10 | |
| Domain | DISIN | 1.26e-03 | 21 | 47 | 2 | SM00050 | |
| Domain | Disintegrin | 1.26e-03 | 21 | 47 | 2 | PF00200 | |
| Domain | Znf_RING | 1.32e-03 | 326 | 47 | 5 | IPR001841 | |
| Domain | Integrin_dom | 1.79e-03 | 25 | 47 | 2 | IPR032695 | |
| Pathway | WP_TROP2_REGULATORY_SIGNALING | 5.53e-06 | 49 | 34 | 4 | M46458 | |
| Pathway | BIOCARTA_SPRY_PATHWAY | 7.03e-06 | 16 | 34 | 3 | MM1500 | |
| Pathway | BIOCARTA_SPRY_PATHWAY | 8.52e-06 | 17 | 34 | 3 | M1389 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | ZNF729 ZNF823 ZNF355P ZNF490 ZNF778 ZNF799 ZNF493 ZNF43 ZNF268 ZNF726 | 8.62e-06 | 768 | 34 | 10 | MM14851 |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 1.21e-05 | 19 | 34 | 3 | MM15113 | |
| Pathway | WP_EBOLA_VIRUS_INFECTION_IN_HOST | 1.34e-05 | 129 | 34 | 5 | M39693 | |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 1.66e-05 | 21 | 34 | 3 | M878 | |
| Pathway | BIOCARTA_ERK_PATHWAY | 3.60e-05 | 27 | 34 | 3 | M287 | |
| Pathway | BIOCARTA_ERK_PATHWAY | 4.03e-05 | 28 | 34 | 3 | MM1391 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 6.06e-05 | 32 | 34 | 3 | MM14854 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 9.42e-05 | 37 | 34 | 3 | M27134 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | ZNF729 ZNF823 ZNF355P ZNF490 ZNF778 ZNF799 ZNF493 ZNF43 ZNF268 ZNF726 | 1.01e-04 | 1022 | 34 | 10 | MM15436 |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.02e-04 | 38 | 34 | 3 | MM14874 | |
| Pathway | WP_FOCAL_ADHESION | 1.06e-04 | 199 | 34 | 5 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.06e-04 | 199 | 34 | 5 | M7253 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.10e-04 | 39 | 34 | 3 | MM14601 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 1.38e-04 | 42 | 34 | 3 | M174 | |
| Pathway | BIOCARTA_EPHA4_PATHWAY | 1.57e-04 | 8 | 34 | 2 | M16334 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.59e-04 | 44 | 34 | 3 | M26969 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.78e-04 | 118 | 34 | 4 | MM15588 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.81e-04 | 46 | 34 | 3 | M239 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.93e-04 | 47 | 34 | 3 | M646 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.96e-04 | 121 | 34 | 4 | M872 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 1.96e-04 | 121 | 34 | 4 | M39823 | |
| Pathway | BIOCARTA_EPHA4_PATHWAY | 2.01e-04 | 9 | 34 | 2 | MM1388 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.32e-04 | 532 | 34 | 7 | M27870 | |
| Pathway | PID_PTP1B_PATHWAY | 2.61e-04 | 52 | 34 | 3 | M50 | |
| Pathway | REACTOME_SIGNALING_BY_EGFR | 2.77e-04 | 53 | 34 | 3 | M27039 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 3.26e-04 | 56 | 34 | 3 | MM17236 | |
| Pathway | BIOCARTA_UCALPAIN_PATHWAY | 3.67e-04 | 12 | 34 | 2 | MM1525 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.80e-04 | 59 | 34 | 3 | M27218 | |
| Pathway | WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM | 3.99e-04 | 60 | 34 | 3 | M40048 | |
| Pathway | BIOCARTA_UCALPAIN_PATHWAY | 5.05e-04 | 14 | 34 | 2 | M13143 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 5.05e-04 | 14 | 34 | 2 | MM14923 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 5.65e-04 | 439 | 34 | 6 | M42563 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 5.77e-04 | 68 | 34 | 3 | MM14968 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 5.82e-04 | 161 | 34 | 4 | M27871 | |
| Pathway | REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING | 6.55e-04 | 71 | 34 | 3 | MM15590 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 7.08e-04 | 300 | 34 | 5 | M610 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 7.29e-04 | 302 | 34 | 5 | M39719 | |
| Pathway | BIOCARTA_TEL_PATHWAY | 7.51e-04 | 17 | 34 | 2 | MM1508 | |
| Pathway | BIOCARTA_TEL_PATHWAY | 7.51e-04 | 17 | 34 | 2 | M10401 | |
| Pathway | REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING | 7.69e-04 | 75 | 34 | 3 | M27874 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 7.99e-04 | 76 | 34 | 3 | M27219 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 8.30e-04 | 77 | 34 | 3 | MM14670 | |
| Pathway | BIOCARTA_PTEN_PATHWAY | 8.43e-04 | 18 | 34 | 2 | M10145 | |
| Pathway | BIOCARTA_MCALPAIN_PATHWAY | 9.41e-04 | 19 | 34 | 2 | MM1434 | |
| Pathway | BIOCARTA_MCALPAIN_PATHWAY | 9.41e-04 | 19 | 34 | 2 | M8719 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 1.01e-03 | 325 | 34 | 5 | M12868 | |
| Pathway | WP_FOCAL_ADHESION | 1.02e-03 | 187 | 34 | 4 | MM15913 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.03e-03 | 326 | 34 | 5 | MM15917 | |
| Pathway | WP_GLIOBLASTOMA_SIGNALING | 1.03e-03 | 83 | 34 | 3 | M39637 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 1.07e-03 | 84 | 34 | 3 | M3228 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.07e-03 | 84 | 34 | 3 | M7098 | |
| Pathway | WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3 | 1.18e-03 | 87 | 34 | 3 | M39465 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF729 ZNF490 ZNF778 ZNF799 ZNF493 EGFR ZNF43 ZNF268 ZNF726 ZNF77 | 1.19e-03 | 1387 | 34 | 10 | M734 |
| Pathway | WP_PI3KAKT_SIGNALING | 1.22e-03 | 339 | 34 | 5 | M39736 | |
| Pathway | KEGG_PROSTATE_CANCER | 1.26e-03 | 89 | 34 | 3 | M13191 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_ATTACHMENT_AND_ENTRY | 1.38e-03 | 23 | 34 | 2 | M48234 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 1.38e-03 | 23 | 34 | 2 | M47537 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 1.38e-03 | 23 | 34 | 2 | M47720 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.48e-03 | 94 | 34 | 3 | M1041 | |
| Pathway | BIOCARTA_TFF_PATHWAY | 1.51e-03 | 24 | 34 | 2 | M15926 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 1.57e-03 | 96 | 34 | 3 | M39834 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 1.64e-03 | 25 | 34 | 2 | M47934 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 1.65e-03 | 213 | 34 | 4 | M18306 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 1.77e-03 | 26 | 34 | 2 | M47 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY | 1.77e-03 | 26 | 34 | 2 | M47719 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 1.91e-03 | 27 | 34 | 2 | M27217 | |
| Pathway | WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING | 2.05e-03 | 28 | 34 | 2 | M39572 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 2.05e-03 | 28 | 34 | 2 | M47655 | |
| Pathway | BIOCARTA_TFF_PATHWAY | 2.20e-03 | 29 | 34 | 2 | MM1522 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.35e-03 | 30 | 34 | 2 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.35e-03 | 30 | 34 | 2 | M27216 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 2.35e-03 | 30 | 34 | 2 | M47724 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 2.35e-03 | 30 | 34 | 2 | M47718 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 2.51e-03 | 31 | 34 | 2 | MM1343 | |
| Pathway | REACTOME_EGFR_DOWNREGULATION | 2.51e-03 | 31 | 34 | 2 | MM14705 | |
| Pathway | REACTOME_EGFR_DOWNREGULATION | 2.51e-03 | 31 | 34 | 2 | M16597 | |
| Pathway | WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING | 2.51e-03 | 31 | 34 | 2 | MM15818 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.68e-03 | 32 | 34 | 2 | MM14924 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 2.84e-03 | 33 | 34 | 2 | M6220 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 3.06e-03 | 418 | 34 | 5 | MM15587 | |
| Pathway | PID_ARF6_PATHWAY | 3.20e-03 | 35 | 34 | 2 | M86 | |
| Pathway | WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING | 3.38e-03 | 36 | 34 | 2 | M39569 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 3.44e-03 | 261 | 34 | 4 | MM15676 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 3.97e-03 | 133 | 34 | 3 | MM15529 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 4.22e-03 | 136 | 34 | 3 | MM14848 | |
| Pathway | PID_ERBB1_INTERNALIZATION_PATHWAY | 4.37e-03 | 41 | 34 | 2 | M214 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 4.37e-03 | 41 | 34 | 2 | M27778 | |
| Pathway | PID_ECADHERIN_STABILIZATION_PATHWAY | 4.37e-03 | 41 | 34 | 2 | M232 | |
| Pathway | PID_TCPTP_PATHWAY | 4.58e-03 | 42 | 34 | 2 | M91 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 4.79e-03 | 43 | 34 | 2 | M53 | |
| Pathway | BIOCARTA_KERATINOCYTE_PATHWAY | 5.47e-03 | 46 | 34 | 2 | M19118 | |
| Pathway | PID_TNF_PATHWAY | 5.47e-03 | 46 | 34 | 2 | M128 | |
| Pathway | BIOCARTA_KERATINOCYTE_PATHWAY | 5.47e-03 | 46 | 34 | 2 | MM1428 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.70e-03 | 47 | 34 | 2 | MM14925 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 5.70e-03 | 47 | 34 | 2 | M39829 | |
| Pathway | PID_AJDISS_2PATHWAY | 5.94e-03 | 48 | 34 | 2 | M142 | |
| Pathway | REACTOME_SIGNALING_BY_EGFR | 6.19e-03 | 49 | 34 | 2 | MM14695 | |
| Pubmed | 1.20e-11 | 15 | 48 | 5 | 15885501 | ||
| Pubmed | Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR. | 6.68e-11 | 49 | 48 | 6 | 9630514 | |
| Pubmed | 1.46e-10 | 181 | 48 | 8 | 37372979 | ||
| Pubmed | 4.68e-10 | 29 | 48 | 5 | 14563677 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 18375753 | ||
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 33477820 | ||
| Pubmed | 8.60e-08 | 7 | 48 | 3 | 12234920 | ||
| Pubmed | 2.81e-07 | 40 | 48 | 4 | 30898150 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 2.90e-07 | 101 | 48 | 5 | 23382219 | |
| Pubmed | 2.94e-07 | 10 | 48 | 3 | 18273061 | ||
| Pubmed | Functional analysis of the SRY-KRAB interaction in mouse sex determination. | 2.94e-07 | 10 | 48 | 3 | 18588511 | |
| Pubmed | Sry associates with the heterochromatin protein 1 complex by interacting with a KRAB domain protein. | 4.04e-07 | 11 | 48 | 3 | 15469996 | |
| Pubmed | 6.99e-07 | 13 | 48 | 3 | 19850934 | ||
| Pubmed | 6.99e-07 | 13 | 48 | 3 | 18077585 | ||
| Pubmed | 9.28e-07 | 383 | 48 | 7 | 19453261 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 15289498 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 26554308 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 15337756 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 24412389 | ||
| Pubmed | β3 integrin is dispensable for conditioned fear and hebbian forms of plasticity in the hippocampus. | 1.87e-06 | 2 | 48 | 2 | 22748100 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 17320820 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 14654552 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 22506015 | ||
| Pubmed | Co-inhibition of EGFR and IGF1R synergistically impacts therapeutically on adrenocortical carcinoma. | 1.87e-06 | 2 | 48 | 2 | 27105537 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 23595626 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 17899316 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 27213344 | ||
| Pubmed | β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells. | 1.87e-06 | 2 | 48 | 2 | 21478906 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 26540287 | ||
| Pubmed | Temporal analysis of ectopic enamel production in incisors from sprouty mutant mice. | 1.87e-06 | 2 | 48 | 2 | 19101957 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 22511753 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 23994953 | ||
| Pubmed | The beta1 and beta3 integrins promote T cell receptor-mediated cytotoxic T lymphocyte activation. | 1.87e-06 | 2 | 48 | 2 | 12690105 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 31618629 | ||
| Pubmed | Insulin activates EGFR by stimulating its interaction with IGF-1R in low-EGFR-expressing TNBC cells. | 1.87e-06 | 2 | 48 | 2 | 25341922 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 27089454 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 28498434 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 25617986 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 17525128 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 22700994 | ||
| Pubmed | β1A integrin is a master regulator of invadosome organization and function. | 1.87e-06 | 2 | 48 | 2 | 20926684 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 24458568 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 21407195 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 24664458 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 25818318 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 14512423 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 22422622 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 23314677 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 20624167 | ||
| Pubmed | Sprouty2 and -4 regulate axon outgrowth by hippocampal neurons. | 1.87e-06 | 2 | 48 | 2 | 21240919 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 25738567 | ||
| Pubmed | Oligodendrocyte Regeneration and CNS Remyelination Require TACE/ADAM17. | 1.87e-06 | 2 | 48 | 2 | 26338334 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 18165225 | ||
| Pubmed | TACE/ADAM17 is essential for oligodendrocyte development and CNS myelination. | 1.87e-06 | 2 | 48 | 2 | 25186737 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 25630587 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 23831057 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 28487468 | ||
| Pubmed | Sprouty2 and Sprouty4 are essential for embryonic morphogenesis and regulation of FGF signaling. | 1.87e-06 | 2 | 48 | 2 | 17156747 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 32845182 | ||
| Pubmed | NELL-1 promotes cell adhesion and differentiation via Integrinβ1. | 1.87e-06 | 2 | 48 | 2 | 22807400 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 18829558 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 22565824 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 22833676 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 19033715 | ||
| Pubmed | siRNA mediated down-regulation of Sprouty2/4 diminishes ischemic brain injury. | 1.87e-06 | 2 | 48 | 2 | 26655476 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 17047074 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 18949375 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 17918158 | ||
| Pubmed | Integrin expression regulates neuroblastoma attachment and migration. | 1.87e-06 | 2 | 48 | 2 | 15256055 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 25948294 | ||
| Pubmed | Extracellular oxidation in cystic fibrosis airway epithelium causes enhanced EGFR/ADAM17 activity. | 1.87e-06 | 2 | 48 | 2 | 29351448 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 34948042 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 16037379 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 19153117 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 24006485 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 39145395 | ||
| Pubmed | Activation of beta 1 but not beta 3 integrin increases cell traction forces. | 1.87e-06 | 2 | 48 | 2 | 23395612 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 26352002 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 21393993 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 20956544 | ||
| Pubmed | Integrins β1 and β3 are biomarkers of uterine condition for embryo transfer. | 1.87e-06 | 2 | 48 | 2 | 27782833 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 19424491 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 31758670 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 22413019 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 26165226 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 21620944 | ||
| Pubmed | ADAM17 transactivates EGFR signaling during embryonic eyelid closure. | 1.87e-06 | 2 | 48 | 2 | 23211830 | |
| Pubmed | SNPs in microRNA-binding sites in the ITGB1 and ITGB3 3'-UTR increase colorectal cancer risk. | 1.87e-06 | 2 | 48 | 2 | 24777809 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 28960861 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 15253384 | ||
| Pubmed | 2.35e-06 | 19 | 48 | 3 | 22629441 | ||
| Pubmed | 2.77e-06 | 20 | 48 | 3 | 7479878 | ||
| Pubmed | 2.77e-06 | 20 | 48 | 3 | 2542606 | ||
| Pubmed | FGF signaling regulates the number of posterior taste papillae by controlling progenitor field size. | 4.89e-06 | 24 | 48 | 3 | 21655085 | |
| Pubmed | 5.42e-06 | 83 | 48 | 4 | 11114734 | ||
| Pubmed | Identification of tyrosine kinases expressed in the male mouse gubernaculum during development. | 5.55e-06 | 25 | 48 | 3 | 15254900 | |
| Pubmed | ERp57 is essential for efficient folding of glycoproteins sharing common structural domains. | 5.55e-06 | 25 | 48 | 3 | 17170699 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 24206174 | ||
| Pubmed | Sprouty4 regulates endothelial cell migration via modulating integrin β3 stability through c-Src. | 5.59e-06 | 3 | 48 | 2 | 23955631 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 30455686 | ||
| Interaction | TRIM28 interactions | ZNF823 ZNF490 ZNF778 ZNF799 TES ZNF229 ZNF493 ZC3H7B UHRF2 EGFR ZNF268 ZNF726 ZNF728 ARIH2 ZNF77 | 9.30e-07 | 1474 | 48 | 15 | int:TRIM28 |
| Interaction | HOXA1 interactions | 1.79e-06 | 356 | 48 | 8 | int:HOXA1 | |
| Interaction | PIK3R2 interactions | 1.70e-05 | 230 | 48 | 6 | int:PIK3R2 | |
| Interaction | GCN1 interactions | 1.76e-05 | 349 | 48 | 7 | int:GCN1 | |
| Interaction | SORL1 interactions | 1.89e-05 | 138 | 48 | 5 | int:SORL1 | |
| Interaction | SPRY2 interactions | 3.01e-05 | 152 | 48 | 5 | int:SPRY2 | |
| Interaction | DNAJC10 interactions | 3.39e-05 | 260 | 48 | 6 | int:DNAJC10 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 1.91e-07 | 122 | 48 | 5 | chr19p12 | |
| Cytoband | 19p12 | 2.52e-06 | 90 | 48 | 4 | 19p12 | |
| Cytoband | 19p13.2 | 1.80e-03 | 229 | 48 | 3 | 19p13.2 | |
| Cytoband | 20q13.12 | 1.82e-03 | 60 | 48 | 2 | 20q13.12 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF729 ZNF823 ZNF490 ZNF778 ZNF799 ZNF80 ZNF229 ZNF493 FEZF1 ZNF43 ZNF268 ZNF726 ZNF728 ZNF77 | 3.61e-11 | 718 | 36 | 14 | 28 |
| GeneFamily | CD molecules|Integrin beta subunits | 1.38e-04 | 9 | 36 | 2 | 1159 | |
| GeneFamily | WAP four-disulfide core domain containing|Fibronectin type III domain containing | 5.78e-04 | 18 | 36 | 2 | 361 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.31e-03 | 27 | 36 | 2 | 47 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 2.87e-03 | 40 | 36 | 2 | 321 | |
| GeneFamily | Fibronectin type III domain containing | 3.92e-03 | 160 | 36 | 3 | 555 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 7.54e-03 | 394 | 36 | 4 | 471 | |
| GeneFamily | PHD finger proteins | 1.38e-02 | 90 | 36 | 2 | 88 | |
| GeneFamily | Ring finger proteins | 1.72e-02 | 275 | 36 | 3 | 58 | |
| Coexpression | NABA_MATRISOME | VWC2L CCN6 NELL1 LAMC1 ADAM29 PI3 ADAM17 LTBP3 BMPER CHRDL2 FST | 1.87e-06 | 1026 | 48 | 11 | M5889 |
| Coexpression | BECKER_TAMOXIFEN_RESISTANCE_DN | 2.93e-06 | 54 | 48 | 4 | M15676 | |
| Coexpression | NABA_MATRISOME | 1.17e-05 | 1008 | 48 | 10 | MM17056 | |
| Coexpression | GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_UP | 1.52e-05 | 171 | 48 | 5 | M8594 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.59e-05 | 191 | 48 | 5 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.93e-05 | 196 | 48 | 5 | M3008 | |
| Coexpression | GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN | 2.93e-05 | 196 | 48 | 5 | M7672 | |
| Coexpression | GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN | 3.08e-05 | 198 | 48 | 5 | M3242 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K4ME3 | 3.18e-05 | 497 | 48 | 7 | MM863 | |
| Coexpression | ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_7DY_DN | 6.86e-05 | 7 | 48 | 2 | M41029 | |
| Coexpression | GAL_LEUKEMIC_STEM_CELL_UP | 9.49e-05 | 130 | 48 | 4 | M17428 | |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3 | 9.89e-05 | 807 | 48 | 8 | MM855 | |
| Coexpression | NABA_CORE_MATRISOME | 1.33e-04 | 270 | 48 | 5 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 1.45e-04 | 275 | 48 | 5 | M5884 | |
| Coexpression | FAN_OVARY_CL11_MURAL_GRANULOSA_CELL | 1.54e-04 | 444 | 48 | 6 | M41713 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN | 1.79e-04 | 457 | 48 | 6 | M14507 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-8|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.88e-07 | 150 | 48 | 5 | 1aa9320d97ff10994ea024751790524fe133aba9 | |
| ToppCell | CV-Mild-4|CV / Virus stimulation, Condition and Cluster | 2.65e-05 | 160 | 48 | 4 | be89efeeecb0de96ce136a7a62738f15dc0badb2 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-05 | 169 | 48 | 4 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 176 | 48 | 4 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.85e-05 | 176 | 48 | 4 | 1af28b701c4598ce761f85adbd5d79e4918d265a | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 176 | 48 | 4 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.11e-05 | 179 | 48 | 4 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.29e-05 | 181 | 48 | 4 | 6e8c5460021d3999daec58e3d6661a6fa998fd16 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.97e-05 | 66 | 48 | 3 | 57fd31a25addc48793d7975eadccf4c5a41a8b03 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.98e-05 | 188 | 48 | 4 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-05 | 189 | 48 | 4 | bba28f57a0708515fdd5acd9592dbbe4a4f57116 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-05 | 189 | 48 | 4 | cf293b23a4c0e8a0c9f09115b1d53d9b11de72e2 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-05 | 189 | 48 | 4 | 6b3b42d758b63a0df62310c34fa3bde421c1afd7 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-05 | 189 | 48 | 4 | 87323e86a5b5d159920a07e6bd7ef5e3438cd085 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-05 | 189 | 48 | 4 | 344b23d3c47d0665dda1cd4856a5e72f1c28cfb3 | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 191 | 48 | 4 | 6cab0334f76c973880bd8d1638856f2f6e4a249a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 191 | 48 | 4 | 850c6fff6dc795431ef534fdaa41e4ad50f7367a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 191 | 48 | 4 | 8b2b00202d3c98bccbae1b4a23713892fad0ff23 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.40e-05 | 192 | 48 | 4 | d0fb6885f023d55a2b7984c99db9c6463258f788 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 192 | 48 | 4 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 193 | 48 | 4 | 316ebdf15f75d88c348f909b643fcd315364ca84 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 193 | 48 | 4 | 1afdd3f7d703f4204a2cbfe40e135ac7b09213f7 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 193 | 48 | 4 | 49600db68ed65cafc67bd45a285b364e4f5f88af | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 193 | 48 | 4 | 8dc6db335678f3a5cfd36026ad811fed8d9cb4bc | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 193 | 48 | 4 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.62e-05 | 194 | 48 | 4 | 8b81f039f5b25d35a4d5a41b27d4d9360ba22f15 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-05 | 194 | 48 | 4 | bc945450b350f597c3ff910d3a14a533d90086a8 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 195 | 48 | 4 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 195 | 48 | 4 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 195 | 48 | 4 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-05 | 196 | 48 | 4 | 65f2f51e17f1869f3468813127b96d3048d8ad41 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-05 | 196 | 48 | 4 | 2cd83176f2e8a9e6fa3c08cb33928a61e5fc43b6 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-05 | 196 | 48 | 4 | e4ed897900a6472738bc6be2fb4817192727225d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.97e-05 | 197 | 48 | 4 | ea746772adb9df4ddb0508d4ef35f2027bf09c35 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.97e-05 | 197 | 48 | 4 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.97e-05 | 197 | 48 | 4 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.97e-05 | 197 | 48 | 4 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.97e-05 | 197 | 48 | 4 | 5a63c2b824c7d0dbbc706e408459c9b9fe65daaa | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.97e-05 | 197 | 48 | 4 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.79e-04 | 131 | 48 | 3 | 5a7bd9d0435e61905e6bd42518953b5aead03e88 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-Tfh|GI_small-bowel / Manually curated celltypes from each tissue | 4.05e-04 | 134 | 48 | 3 | bf94ce5edde8912a27010e229c313d8102d6de62 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Whrn_Tox2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.90e-04 | 143 | 48 | 3 | 36ce6f163fb33141c86288086c354b91853fad25 | |
| ToppCell | facs-Trachea-nan-18m-Mesenchymal-smooth_muscle_cell_of_trachea|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-04 | 151 | 48 | 3 | 5aa98ca9abe37edbc750fd970852a1cc903a5881 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.85e-04 | 152 | 48 | 3 | f748ee34167f79ecda116aa1914afab47403385a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-midbrain/hindbrain_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 6.08e-04 | 154 | 48 | 3 | df1b58a20af73fa79c6c069c0117a9ffd85b476f | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.31e-04 | 156 | 48 | 3 | fc8b8aef29d6d1c0f0c1d08280d8aaff8d30535e | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-Teffector/EM_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 6.31e-04 | 156 | 48 | 3 | e308328f560c5ee7e9f95ac5db162f2d821ca39c | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.43e-04 | 157 | 48 | 3 | f6210be2362d833c6d869ff921188bfc85dda11d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.43e-04 | 157 | 48 | 3 | 43a6b423fd70479822a564ff4225a1e4951ae5ed | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.54e-04 | 158 | 48 | 3 | c736834269c89e003c61a62b63e4e50dbf0e1538 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.91e-04 | 161 | 48 | 3 | 3b5d7a3dab479c6959a428f3954dedd989900276 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.55e-04 | 166 | 48 | 3 | 37f5264491d75af690dd94eea2cf7763f42b2a2a | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.68e-04 | 167 | 48 | 3 | fe3338f99f94c0dac37e3d649dfdce82e4a56022 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-04 | 167 | 48 | 3 | aef22535a76e93472bcedacbb2c6991f3c9c8cd5 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.82e-04 | 168 | 48 | 3 | 74d6dbf9295933acdee785af9b73a94377d15412 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.82e-04 | 168 | 48 | 3 | f3879a8e11eaf866f37c52e67021be43f0b8784a | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.95e-04 | 169 | 48 | 3 | d382a76d85875663502cc7dde2e3e0682605768e | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 7.95e-04 | 169 | 48 | 3 | 150c08c7b1dc0f46173a7b8f6a3fc70d82906c0d | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.09e-04 | 170 | 48 | 3 | 67415b098e8ba815b501e557192a9f2b10ee995a | |
| ToppCell | Basal_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 8.09e-04 | 170 | 48 | 3 | 776d4224a682b6c648041827efd69794f88906f0 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 8.23e-04 | 171 | 48 | 3 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.23e-04 | 171 | 48 | 3 | fe0665c5ca01b0b2cc8f20d64587f0847c3d215c | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-04 | 172 | 48 | 3 | b3c4adccc34bb9e4e78e40f4e2e23736c347cc75 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-04 | 172 | 48 | 3 | 2f1673fcb2356684d60871debb0f159aec553a1c | |
| ToppCell | NS-critical-d_0-4-Epithelial-FOXN4+|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.37e-04 | 172 | 48 | 3 | a00bb44d33658cb3a98accd6b60f3ce964c425b4 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-04 | 173 | 48 | 3 | 53e97835d7a518c278e7b90a0734eb0095d6aa33 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.51e-04 | 173 | 48 | 3 | 117163c5cd2b7aaa1c0682c8ac44b4249df4d2f8 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-04 | 173 | 48 | 3 | 3612772632ddf11eb48579cae9a8ccab6b3f1f52 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.51e-04 | 173 | 48 | 3 | 7a3115e7cf7e2f345192cde0656a7f0193594a5f | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-04 | 173 | 48 | 3 | 889a880de5fc19d26b82cfef3067869a28ef17ca | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-04 | 173 | 48 | 3 | 4dc261ebcdb9bdcfca1451da1bd254f0dc5de203 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.51e-04 | 173 | 48 | 3 | 01df9baeedf30e3a4891738554cdd300394dbb96 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-04 | 174 | 48 | 3 | 68a6ed81e7e1f95b61f7ee20403980fa3a8db4d0 | |
| ToppCell | CV-Healthy-4|Healthy / Virus stimulation, Condition and Cluster | 8.65e-04 | 174 | 48 | 3 | 26544cc5f51cb4dc1251e62d9f80b6c956194d38 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.80e-04 | 175 | 48 | 3 | 4bfae78ac3a2cb9404382aae96d291504a9cfa14 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.80e-04 | 175 | 48 | 3 | 2e54961846c65b185d9bd6e305dd81205579d890 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.80e-04 | 175 | 48 | 3 | af9c5104c86231cfdb93a0f7d7032379efaa009e | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.80e-04 | 175 | 48 | 3 | f1394aacc8a94ca555dd19aaed5a18da99c6bf40 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.80e-04 | 175 | 48 | 3 | a84965d28438a4228d841b357c2cd75cf4b59a63 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.80e-04 | 175 | 48 | 3 | efa6a05f7417d46141b6e635f258c126b7a03aa1 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.80e-04 | 175 | 48 | 3 | 7bf1194d93fbe2dbf9d953e0a32b2a6d88251ed1 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.09e-04 | 177 | 48 | 3 | 68263456a3c93cd195b321b309ff59e156d732fe | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.09e-04 | 177 | 48 | 3 | e415e448c37adc102d766235e9953dec32c021f1 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.24e-04 | 178 | 48 | 3 | 3d120458a0a56097532ebfa5fc6f77b52af2af2a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.39e-04 | 179 | 48 | 3 | cd7f0e8f4abb2a2bac366c8910c8c5fda841dbce | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 9.39e-04 | 179 | 48 | 3 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | CV-Severe-4|Severe / Virus stimulation, Condition and Cluster | 9.54e-04 | 180 | 48 | 3 | cf84a01e6a33e5d27ad7be1d9069a0370b5116d1 | |
| ToppCell | Neuroendocrine-neuroendo-1|World / Class top | 9.54e-04 | 180 | 48 | 3 | 50fdd182a083380899b5943cb5f55ffd77e2a7d4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.54e-04 | 180 | 48 | 3 | c6030e725e3d86d5d74a1676330c77ffeceb324f | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.70e-04 | 181 | 48 | 3 | 1037051eb82313c13346617b33f3c4c648181c4d | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.70e-04 | 181 | 48 | 3 | 8950844b3e65c7028d80da5787ae2ce509c3d52d | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.85e-04 | 182 | 48 | 3 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | CV-Severe-4|CV / Virus stimulation, Condition and Cluster | 9.85e-04 | 182 | 48 | 3 | c19bbc43d97c426aec37414f46f667a19b62a257 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.00e-03 | 183 | 48 | 3 | b5d041d0a3506c33de72bf14fa0443f4410fddf1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.00e-03 | 183 | 48 | 3 | 274076a0978bce2bd53a1732045f18ef0f2d9985 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.00e-03 | 183 | 48 | 3 | 5377b4fbd8fdfe68933b4c0965aa9525f7f31591 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-03 | 184 | 48 | 3 | e93633d89a9c54c8d2819f56372815b4ca149f06 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-03 | 185 | 48 | 3 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-03 | 185 | 48 | 3 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-03 | 185 | 48 | 3 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| Drug | methyl ethyl ketone | 2.64e-07 | 587 | 47 | 10 | CID000006569 | |
| Drug | tAPE | 7.81e-06 | 19 | 47 | 3 | CID000069007 | |
| Drug | AC1NRBJE | 1.52e-05 | 152 | 47 | 5 | CID005288446 | |
| Drug | sorafenib | 1.83e-05 | 158 | 47 | 5 | CID000216239 | |
| Drug | imatinib | 2.67e-05 | 430 | 47 | 7 | CID000005291 | |
| Drug | 3-quinolinecarbonitrile | 4.15e-05 | 5 | 47 | 2 | CID000093177 | |
| Drug | 2-(2,6-dioxopiperidin-3-yl)phthalimidine | 4.15e-05 | 5 | 47 | 2 | ctd:C001079 | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Up 200; 9.6uM; PC3; HT_HG-U133A | 5.01e-05 | 195 | 47 | 5 | 7309_UP | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 5.01e-05 | 195 | 47 | 5 | 3327_UP | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; HL60; HG-U133A | 5.14e-05 | 196 | 47 | 5 | 1379_UP | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; HL60; HG-U133A | 5.14e-05 | 196 | 47 | 5 | 2015_UP | |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; HL60; HT_HG-U133A | 5.14e-05 | 196 | 47 | 5 | 2179_DN | |
| Disease | Neonatal inflammatory skin and bowel disease | 2.48e-06 | 2 | 47 | 2 | C4751120 | |
| Disease | high grade glioma (implicated_via_orthology) | 4.79e-05 | 44 | 47 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | alcohol dependence (implicated_via_orthology) | 8.88e-05 | 9 | 47 | 2 | DOID:0050741 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 1.15e-04 | 702 | 47 | 7 | C0009402 | |
| Disease | HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA | 1.35e-04 | 11 | 47 | 2 | 146110 | |
| Disease | sleep disorder (implicated_via_orthology) | 1.35e-04 | 11 | 47 | 2 | DOID:535 (implicated_via_orthology) | |
| Disease | Hypogonadotropic hypogonadism 7 with or without anosmia | 1.35e-04 | 11 | 47 | 2 | cv:C0342384 | |
| Disease | median neuropathy (biomarker_via_orthology) | 2.23e-04 | 14 | 47 | 2 | DOID:571 (biomarker_via_orthology) | |
| Disease | diabetic neuropathy (implicated_via_orthology) | 2.23e-04 | 14 | 47 | 2 | DOID:9743 (implicated_via_orthology) | |
| Disease | Graves' disease (is_marker_for) | 2.57e-04 | 15 | 47 | 2 | DOID:12361 (is_marker_for) | |
| Disease | Astrocytosis | 3.33e-04 | 17 | 47 | 2 | C3887640 | |
| Disease | Gliosis | 3.33e-04 | 17 | 47 | 2 | C0017639 | |
| Disease | Idiopathic hypogonadotropic hypogonadism | 3.74e-04 | 18 | 47 | 2 | C0342384 | |
| Disease | Adrenocortical carcinoma | 3.74e-04 | 18 | 47 | 2 | C0206686 | |
| Disease | left ventricular structural measurement | 3.78e-04 | 88 | 47 | 3 | EFO_0008205 | |
| Disease | inflammatory bowel disease (is_implicated_in) | 4.17e-04 | 19 | 47 | 2 | DOID:0050589 (is_implicated_in) | |
| Disease | taurocholate measurement | 4.63e-04 | 20 | 47 | 2 | EFO_0010538 | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 4.63e-04 | 20 | 47 | 2 | DOID:2921 (biomarker_via_orthology) | |
| Disease | corpus callosum volume measurement | 5.50e-04 | 100 | 47 | 3 | EFO_0010299 | |
| Disease | Glioblastoma Multiforme | 7.45e-04 | 111 | 47 | 3 | C1621958 | |
| Disease | diabetes mellitus (implicated_via_orthology) | 7.88e-04 | 26 | 47 | 2 | DOID:9351 (implicated_via_orthology) | |
| Disease | Kallmann Syndrome | 7.88e-04 | 26 | 47 | 2 | C0162809 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 9.14e-04 | 28 | 47 | 2 | DOID:4194 (implicated_via_orthology) | |
| Disease | IgA glomerulonephritis (is_implicated_in) | 1.05e-03 | 30 | 47 | 2 | DOID:2986 (is_implicated_in) | |
| Disease | Squamous cell carcinoma of lung | 1.19e-03 | 32 | 47 | 2 | C0149782 | |
| Disease | Growth Disorders | 1.51e-03 | 36 | 47 | 2 | C0018273 | |
| Disease | testicular carcinoma | 1.86e-03 | 40 | 47 | 2 | EFO_0005088 | |
| Disease | diabetes mellitus (is_marker_for) | 1.96e-03 | 41 | 47 | 2 | DOID:9351 (is_marker_for) | |
| Disease | Craniofacial Abnormalities | 1.98e-03 | 156 | 47 | 3 | C0376634 | |
| Disease | Non-Small Cell Lung Carcinoma | 1.98e-03 | 156 | 47 | 3 | C0007131 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 2.49e-03 | 169 | 47 | 3 | DOID:3908 (is_marker_for) | |
| Disease | Cardiomyopathy, Dilated | 2.67e-03 | 48 | 47 | 2 | C0007193 | |
| Disease | Cardiomyopathy, Familial Idiopathic | 2.90e-03 | 50 | 47 | 2 | C1449563 | |
| Disease | waist-hip ratio | 3.09e-03 | 1226 | 47 | 7 | EFO_0004343 | |
| Disease | Neoplasm Invasiveness | 3.16e-03 | 184 | 47 | 3 | C0027626 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CDCGPLKHCAKDPCC | 411 | Q9UKF5 | |
| LCCKDCKFLPSGKVC | 441 | Q9UKF5 | |
| DCPKCNICIEKNGGC | 296 | O95376 | |
| GICECGVCKCTDPKF | 611 | P05556 | |
| PKCEQKCESKCQPSC | 21 | Q5T871 | |
| CKKCGAGDPSKCRPC | 366 | P54764 | |
| KGPCCACPKTEAEKQ | 696 | P08069 | |
| RCLKDTDCPGIKKCC | 91 | P19957 | |
| TDCPGIKKCCEGSCG | 96 | P19957 | |
| CKETCENVDCGPGKK | 91 | P19883 | |
| ECEKCAKDCVCKGGE | 41 | P25713 | |
| VAGKCCKICPEDKAD | 306 | Q6WN34 | |
| QCCKVCRPKCIYGGK | 326 | Q92832 | |
| ATPFVLCCKCKCSKG | 271 | P50876 | |
| LCCKCKCSKGDDDPL | 276 | P50876 | |
| GCGCCKICAKQPGEI | 71 | O95389 | |
| CKKCEGPCRKVCNGI | 326 | P00533 | |
| KGCCPICTEKPGVCT | 351 | Q8N8U9 | |
| GKCENKPGSFKCIAC | 716 | Q9NS15 | |
| FCHKCEGLCPKECKV | 316 | P14616 | |
| KCPTCPDACTFKKEC | 626 | P05106 | |
| CSCKPGVMGDKCDRC | 416 | P11047 | |
| ACGKCKCKECASPRT | 161 | Q9C004 | |
| QGFGAPCLKCKEKCE | 16 | Q9UGI8 | |
| DKKPFTCPTCGKGFC | 396 | A0PJY2 | |
| CGKCKCKECTYPRPL | 181 | O43597 | |
| GKCKDGKCIPFCERE | 571 | P78536 | |
| CEKIKKACGNFGIPC | 281 | P22234 | |
| VCPKFPLTCDGCGKK | 181 | Q12933 | |
| CDLCGGDPEKKCHSC | 331 | Q96PU4 | |
| PGVKKCCTLGCNKSC | 96 | Q8IUB2 | |
| ILACPKGFKCCGDSC | 31 | Q6UXU6 | |
| PHKCKICGKGFDCPS | 331 | P16415 | |
| EKPCQCKHCGKAFTC | 321 | Q15935 | |
| EKPCECKECGKAFTG | 306 | Q96MU6 | |
| GEKPCKCTECGKAFC | 916 | Q14587 | |
| VKPCECKQCGKAFTC | 471 | Q9ULM2 | |
| GEKPCKCEECGKAFG | 336 | P0DKX0 | |
| PHKCKICGKGFDCPS | 336 | Q96GE5 | |
| KGFPKSCCKLEDCTP | 171 | O43657 | |
| KCEKGGRLLCCESCP | 916 | Q9BZ95 | |
| IDKPCGCNKCRKDCI | 236 | Q9UJW7 | |
| FCKCEKCGKAFNCPS | 201 | P17038 | |
| GEKPCKCEECGKAFS | 281 | A6NNF4 | |
| GEKPCKCVECGKVFN | 101 | P51504 | |
| KCTKVEHNGCCPECK | 96 | B2RUY7 | |
| GEKPCKCEECGKAFN | 581 | Q6ZR52 | |
| GEVIYKCPKCCCIKP | 126 | Q9NXF8 | |
| PCKCEECGKACKQSL | 211 | Q9NSJ1 | |
| TGEKPCKCEECDKAF | 1071 | A6NN14 | |
| QKGKACPDGDKCRCA | 896 | Q9UGR2 |